NEVIRAPINE SCP nevirapine 200 mg tablet blister pack

Χώρα: Αυστραλία

Γλώσσα: Αγγλικά

Πηγή: Department of Health (Therapeutic Goods Administration)

Δραστική ουσία:

nevirapine, Quantity: 200 mg

Διαθέσιμο από:

Southern Cross Pharma Pty Ltd

INN (Διεθνής Όνομα):

Nevirapine

Φαρμακοτεχνική μορφή:

Tablet, uncoated

Σύνθεση:

Excipient Ingredients: colloidal anhydrous silica; sodium starch glycollate type A; povidone; lactose monohydrate; microcrystalline cellulose; magnesium stearate

Οδός χορήγησης:

Oral

Μονάδες σε πακέτο:

60, 100, 14

Τρόπος διάθεσης:

(S4) Prescription Only Medicine

Θεραπευτικές ενδείξεις:

NEVIRAPINE SCP immediate-release tablets in combination with antiretroviral agents are indicated for the treatment of HIV-1 infection in adults and adolescents over the age of 16 years. Resistant virus emerges rapidly when NEVIRAPINE SCP is administered as monotherapy or in dual combination therapy with an antiretroviral agent. Therefore, NEVIRAPINE SCP should always be administered in combination with at least two additional antiretroviral agents.

Περίληψη προϊόντος:

Visual Identification: White to off-white, oblong tablets with '200' embossed on one side and 'NVP' on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Καθεστώς αδειοδότησης:

Licence status A

Ημερομηνία της άδειας:

2013-07-30